Research Department of Infection and Population Health, University College London, London, United Kingdom.
J Acquir Immune Defic Syndr. 2010 Jul;54(3):275-84. doi: 10.1097/qai.0b013e3181d32158.
The effect of interruption of antiretroviral therapy (ART) on lipoprotein particle subclasses has not been studied. We examined short-term changes in lipids and lipoprotein particles among 332 HIV-infected individuals randomized to interrupt or continue ART in the "Strategies for Management of Antiretroviral Therapy" trial.
Lipids and lipoprotein particles measured by nuclear magnetic resonance spectroscopy were compared between randomized groups at month 1; associations with inflammatory and coagulation markers (high sensitivity C-reactive protein; interleukin 6; amyloid A; amyloid P; D-dimer; prothrombin fragment 1 + 2) were assessed.
Compared with continuation of ART, treatment interruption resulted in substantial declines in total, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol, and triglyceride, at month 1 but had little net effect on total/HDL cholesterol ratio [baseline-adjusted mean difference [95% confidence interval (CI)] interruption versus continuation arms: -0.10 (-0.59 to 0.38); P = 0.67]. ART interruption resulted in declines in total, large, and medium very low density lipoprotein (VLDL) particle concentrations (VLDL-p) and total and medium HDL-p. However, there was no change in small HDL-p [baseline-adjusted percentage difference between arms: -4.6% (-13.1%, +5.1% ); P = 0.35], small LDL-p [-5.0% (-16.9%, +8.6%); P = 0.45], or other LDL-p subclasses. Changes in lipid parameters on ART interruption did not differ according to baseline ART class (protease inhibitor versus non-nucleoside reverse transcriptase inhibitor) but were negatively associated both with changes in HIV viral load and with changes in inflammatory and coagulation markers, particularly D-dimer.
These results suggest that ART interruption does not favorably influence overall lipid profile: there was little net effect on total/HDL cholesterol ratio, and no change in small LDL-p or small HDL-p, the lipoprotein particle subclasses most consistently linked to coronary risk. Short-term declines in lipid parameters after ART interruption were not associated with class of ART and may be linked to increases in viral replication, inflammation and coagulation.
抗逆转录病毒疗法(ART)中断对脂蛋白颗粒亚类的影响尚未得到研究。我们在“管理抗逆转录病毒治疗策略”试验中,检查了 332 名随机分为中断或继续 ART 的 HIV 感染个体的短期血脂和脂蛋白颗粒变化。
通过核磁共振光谱法测量的脂质和脂蛋白颗粒在第 1 个月时在随机组之间进行比较;评估与炎症和凝血标志物(高敏 C 反应蛋白;白细胞介素 6;淀粉样 A;淀粉样蛋白 P;D-二聚体;凝血酶原片段 1 + 2)的相关性。
与继续 ART 相比,治疗中断在第 1 个月导致总胆固醇、低密度脂蛋白(LDL)和高密度脂蛋白(HDL)胆固醇以及甘油三酯大幅下降,但对总/HDL 胆固醇比值几乎没有净影响[基线调整平均差异[95%置信区间(CI)]中断与继续臂:-0.10(-0.59 至 0.38);P = 0.67]。ART 中断导致总胆固醇、大、中极低密度脂蛋白(VLDL)颗粒浓度(VLDL-p)以及总胆固醇和中 HDL-p 的下降。然而,小 HDL-p 没有变化[臂间基线调整百分比差异:-4.6%(-13.1%,+5.1%);P = 0.35],小 LDL-p[-5.0%(-16.9%,+8.6%);P = 0.45],或其他 LDL-p 亚类。ART 中断时脂质参数的变化与基线 ART 类别(蛋白酶抑制剂与非核苷逆转录酶抑制剂)无关,但与 HIV 病毒载量的变化以及炎症和凝血标志物的变化呈负相关,尤其是 D-二聚体。
这些结果表明,ART 中断不利于整体血脂谱:总/HDL 胆固醇比值几乎没有净影响,小 LDL-p 或小 HDL-p 没有变化,这是与冠心病风险最密切相关的脂蛋白颗粒亚类。ART 中断后短期脂质参数下降与 ART 类别无关,可能与病毒复制、炎症和凝血增加有关。